19.04.2018 • News

DSM Dyneema Ends Patent Dispute with FMS

DSM Dyneema Ends Patent Dispute with FMS
DSM Dyneema Ends Patent Dispute with FMS

DSM Dyneema has concluded a dispute with Israeli firm FMS Enterprises Migun (FMS) relating to the infringement and validity of the Dutch company’s patents for ultra-high molecular weight polyethylene (UHMWPE).

Details of the agreement were not disclosed

This is the final step in a series of disputes between the two, including earlier unsuccessful attempts by FMS to challenge the validity of DSM Dyneema’s patent on an improved UHMWPE.

The latest action by DSM Dyneema against FMS was filed in November 2017 and was concluded in March this year.

“We are very pleased with this outcome, which again confirms the quality of our patents,” said Olivier Janin, vice president, marketing and sales at DSM Dyneema, adding that the company has consistently and vigorously defended its intellectual property on many occasions and will continue to do so.

DSM Dyneema has also ended another dispute with FMS relating to a patent concerning improved unidirectional sheets and pressed protective life saving articles made of such sheets, including inserts, helmets and vehicle panels. FMS had opposed DSM Dyneema’s patent, which was eventually granted on Mar. 22, 2018.

 

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.